CSTL beat EPS expectations by 72.60%
Feb 26, 2026, 11:32 PM
0.00%
What does CSTL do
Castle Biosciences, headquartered in Friendswood, Texas, is a dermatological cancer company that provides genomic tests for skin cancers and mental health conditions. The firm went public in July 2019 and employs 610 people.
Castle Biosciences (CSTL) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Castle Biosciences's actual EPS was -$0.08, beating the estimate of -$0.29 per share, resulting in a 72.60% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.